Industry Insights

• 
  2025 Q1: Oncology Business Competition Among MNCs Xiaobin
  June 04, 2025
  How did MNCs fare in the oncology field during Q1 of this year?
• 
  Comparison of Improved New Drugs Paths between China and the United States and Analysis of R&D Status in China Kevin
  April 28, 2025
  This article describes successful practices from the United States 505(b)(2) pathway and analyzes R&D status of China's modified new drugs.
• 
  Taking Over the "King of Medicine"? Chinese Enterprises Lead the Development of PD-(L)1/VEGF Bispecific Antibody Antitumor Drug Kevin
  April 28, 2025
  PD-(L)1 and VEGF (vascular endothelial growth factor) bispecific antibody therapies are considered a key direction for future tumor treatments, attracting increasing global interest due to their unique mechanism of action and promising clinical data.

• 
  Predicted Top 5 Worldwide Selling Drugs in 2025: A Market Update David Orchard-Webb
  June 23, 2025
  Keytruda ($30B sales), Ozempic, Mounjaro, Dupixent, and Skyrizi dominate 2025's pharma market, targeting oncology, diabetes/obesity, and immunology with breakthrough biologics and multi-indication strategies.

• 
  InnoCare Announces Approval of Clinical Trial of a Novel ADC ICP-B794 in China PharmaSources
  July 04, 2025
• 
  Invetech and AiCella Announce Strategic Collaboration to Advance Cell Therapy Innovation PR Newswire
  June 27, 2025
• 
  Infosys and the Mental Health Foundation Australia Launch 'Supportive Mind' App to Boost Mental Health PR Newswire
  June 26, 2025
  Infosys, a global leader in next-generation digital services and consulting, today announced a strategic collaboration with Mental Health Foundation Australia to further amplify mental health awareness, with thecreation of a mobile app.

• 
  Popular Products and Companies at PharmaSources.com (January 2025) PSI
  January 15, 2025
  Popular Products and Companies at PharmaSources.com
• 
  Research and Application of Artemisia Argyi Xiaonisha
  August 12, 2024
• 
  Research Progress on the Application of Biologics in Pediatric Asthma Xiaomichong
  July 19, 2024

• 
  Apeloa Pharmaceutical releases first ESG PharmaSources
  May 12, 2025
  Apeloa Pharmaceutical has released its first sustainability report. Apeloa’s 2024 Environmental, Social and Governance (ESG) report marks the start of continuous and responsible disclosure into the future.